Viridian Therapeutics, Inc.
VRDN
$13.13
$0.483.79%
NASDAQ
12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
---|---|---|---|---|---|
Total Cash And Short-Term Investments | -4.73% | 31.83% | -6.82% | 28.45% | 52.51% |
Total Receivables | -- | -- | -- | 0.00% | 0.00% |
Inventory | -- | -- | -- | -- | -- |
Prepaid Expenses | 48.03% | 36.95% | -23.88% | 50.22% | -16.07% |
Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
Other Current Assets | -- | -- | -- | -- | -- |
Total Current Assets | -3.77% | 31.92% | -7.20% | 28.85% | 50.22% |
|
|||||
Total Current Assets | -3.77% | 31.92% | -7.20% | 28.85% | 50.22% |
Net Property, Plant & Equipment | -6.75% | 10.48% | 11.04% | -9.99% | -8.56% |
Long-term Investments | -- | -- | -- | -- | -- |
Goodwill | -- | -- | -- | -- | -- |
Total Other Intangibles | -- | -- | -- | -- | -- |
Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
Total Other Assets | -41.27% | 29.44% | 18.74% | -8.11% | -52.18% |
Total Assets | -3.82% | 31.80% | -7.09% | 28.54% | 49.18% |
|
|||||
Total Accounts Payable | -66.19% | 101.85% | 17.34% | 19.52% | -40.05% |
Total Accrued Expenses | 31.66% | 14.40% | 33.28% | -3.60% | 26.56% |
Short-term Debt | -- | -- | -- | -- | -- |
Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
Finance Division Debt Current | -12.90% | -83.03% | 374.18% | -13.17% | 2.68% |
Total Finance Division Other Current Liabilities | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Total Other Current Liabilities | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Total Current Liabilities | 15.74% | 12.52% | 40.71% | -1.91% | 14.57% |
|
|||||
Total Current Liabilities | 15.74% | 12.52% | 40.71% | -1.91% | 14.57% |
Long-Term Debt | 0.29% | 17.36% | -13.98% | 0.61% | 1.03% |
Short-term Debt | -- | -- | -- | -- | -- |
Capital Leases | -6.34% | 31.21% | 83.82% | -9.40% | -23.27% |
Finance Division Debt Non Current | -- | -- | -- | -- | -- |
Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
Total Other Liabilities | -20.22% | -17.02% | -14.20% | -12.74% | -11.16% |
Total Liabilities | 9.88% | 14.34% | 17.71% | -1.14% | 7.13% |
|
|||||
Common Stock & APIC | 3.13% | 22.59% | 1.03% | 20.45% | 18.98% |
Retained Earnings | -8.70% | -9.14% | -8.39% | -6.69% | -10.14% |
Treasury Stock & Other | -101.07% | 271.64% | -47.96% | -208.58% | 628.13% |
Total Common Equity | -6.91% | 57.33% | -13.89% | 62.55% | 58.41% |
|
|||||
Preferred Stock Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Convertible | 0.00% | -5.42% | 0.00% | -3.30% | 53.07% |
Preferred Stock, Others | -- | -- | -- | -- | -- |
Total Preferred Equity | 0.00% | -5.42% | 0.00% | -3.30% | 53.07% |
|
|||||
Total Common Equity | -6.91% | 57.33% | -13.89% | 62.55% | 58.41% |
Total Preferred Equity | 0.00% | -5.42% | 0.00% | -3.30% | 53.07% |
Total Minority Interest | -- | -- | -- | -- | -- |
Total Equity | -5.07% | 33.66% | -9.13% | 31.79% | 55.87% |
|